WHO Recommends Removing Cannabis from List of Most Dangerous Drugs a Strong Indication of Softening Stance
The World Health Organization (WHO) took the fairly radical step of recommending cannabis be removed from the list of most dangerous drugs. Some see it as a move towards accepting cannabis legalization.
Cannabis was added to Schedule IV – the most restrictive category – of the United Nations’ drug convention in 1961. Many countries including Canada and the United States signed the convention. Although not legally binding at the national level, Canada was officially warned by the UN when it legalized cannabis in October 2018. That warning stated that Canada’s legalization of cannabis was “incompatible with obligations” of signed UN treaty
Currently, WHO lists cannabis as a Schedule IV drug, putting it on the same level as drugs such as heroin.
Some also see the move as a sign that WHO is getting ready to accept that medical cannabis has health benefits.
“The placement of cannabis in the 1961 treaty, in the absence of scientific evidence, was a terrible injustice,” said Michael Krawitz, a US Air Force veteran and legalization advocate in the United States. “Today WHO has gone a long way towards setting the record straight. It is time for us all to support the WHO’s recommendations and ensure politics don’t trump science.”
UN Members Not Voting Directly on Cannabis Legalization
Now that WHO has announced its intentions, the proposal will go to the UN’s Commission on Narcotic Drugs. Fifty-three member nations will then have the opportunity to review the proposal, and ultimately vote to accept or reject.
However, even if the recommendations are accepted, technically Canada will still be in contravention of the treaty. WHO calls to reschedule cannabis as a Schedule I drug, so any country that legalizes cannabis would be in violation.
According to Bloomberg (please follow the link below), it is not clear how the US will vote. The country seems to be on its own path to cannabis legalization, and many states have legalized cannabis for medical use and even recreational use.
However, the US Food and Drug Administration (FDA) determined that CBD, a compound found in cannabis, shouldn’t be federally controlled, other than its international obligations. Indeed, even companies like Neiman Marcus are opening selling CBD-based beauty products on store shelves.
“If treaty obligations do not require control of CBD, or if the international controls on CBD change in the future, this recommendation will need to be promptly revisited,” the FDA wrote. That’s not quite a call for cannabis legalization in the United States, but it’s close.
This editorial content from the LPC News Editor is meant to provide analysis, insight, and perspective on current news articles. To read the source article this commentary is based upon, please click on the link below.